Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
110909401000001113 | Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
110909501000001112 | Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials 1 vial | Has VMP | True | Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials | Inferred relationship | Existential restriction modifier | |
Levovist powder and solvent for suspension for injection 2.5g vials (Schering Health Care Ltd) | Is a | True | Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets